false
Hamburger Menu
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Create Account
Forgot Password
Previous
Next
Search
select
10 miles
50 miles
100 miles
250 miles
500 miles
Search by map
Education
Browse:
Conferences
World (WCLC) (12)
Asia (ACLC) (2)
Europe (ELCC) (1)
Latin America (LALCA) (3)
Immunotherapy (IO) (2)
North America (NACLC) (7)
Mesothelioma (MESO) (1)
Small Cell (SCLC) (2)
Targeted Therapies (TTLC) (10)
Education
Courses (7)
Microlearning (5)
Podcasts (245)
Simulations (1)
Webinars (29)
Tools/Resources
Atlases (11)
Language Guide (1)
Staging Resources (2)
Tobacco Control (93)
Type of Thoracic Cancer
Non-small cell lung cancer (198)
Small cell & Other Neuro-endocrine tumors (210)
Mesothelioma (71)
Thymic (41)
Specialty/Discipline
Allied Health (35)
Basic Science (20)
Medical Oncology (186)
Nursing (36)
Pathology (57)
Patient Advocacy (66)
Population Health (39)
Pulmonary Medicine (48)
Radiation Oncology (74)
Radiology (22)
Statistics (18)
Thoracic Oncology (186)
Thoracic Surgery (67)
Translational Science (89)
Publications
IASLC Lung Cancer News (ILCN) (34)
IASLC Position Statements (7)
Journal of Thoracic Oncology (JTO) (70)
JTO Clinical and Research Reports (32)
Language Guide (1)
Featured
Catalog
Sort By
select
Price: Low to High
Price: High to Low
Highest Rating
Popularity
Most Recent
Oldest First
Alphabetical (A-Z)
Alphabetical (Z-A)
Most Relevant
Catalog Display Mode
Catalog Display Mode
IASLC's 50th Anniversary: The IASLC's Future
Podcast | English | 2024 | 41 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
IASLC's 50th Anniversary: The IASLC's Future
Podcast | English | 2024 | 41 Min
No Credit
Free
IASLC's 50th Anniversary: The IASLC Today
Podcast | English | 2024 | 41 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
IASLC's 50th Anniversary: The IASLC Today
Podcast | English | 2024 | 41 Min
No Credit
Free
FDA Approval: MARIPOSA, First-Line Amivantamab plus Lazertinib for EGFR NSCLC
Podcast | English | 2024 | 28 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
FDA Approval: MARIPOSA, First-Line Amivantamab plus Lazertinib for EGFR NSCLC
Podcast | English | 2024 | 28 Min
No Credit
Free
IASLC 50th Anniversary: The First Decade
Podcast | English | 2024 | 52 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
IASLC 50th Anniversary: The First Decade
Podcast | English | 2024 | 52 Min
No Credit
Free
Lung Cancer Considered in Mandarin
Podcast | Mandarin Chinese | 2024 | 40 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Lung Cancer Considered in Mandarin
Podcast | Mandarin Chinese | 2024 | 40 Min
No Credit
Free
WCLC 2024 Preview
Podcast | English | 2024 | 42 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
WCLC 2024 Preview
Podcast | English | 2024 | 42 Min
No Credit
Free
Lung Cancer Considered in Spanish: Neoadjuvant Therapies In NSCLC
Podcast | Spanish | 2024 | 46 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Lung Cancer Considered in Spanish: Neoadjuvant Therapies In NSCLC
Podcast | Spanish | 2024 | 46 Min
No Credit
Free
Seminal Trial Series: Crizotinib in PROFILE 1001
Podcast | English | 2024 | 56 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Seminal Trial Series: Crizotinib in PROFILE 1001
Podcast | English | 2024 | 56 Min
No Credit
Free
Lung Cancer Considered in Farsi
Podcast | Farsi | 2024 | 54 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Lung Cancer Considered in Farsi
Podcast | Farsi | 2024 | 54 Min
No Credit
Free
Immunotherapy in Driver-Positive NSCLC
Podcast | English | 2024 | 47 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Immunotherapy in Driver-Positive NSCLC
Podcast | English | 2024 | 47 Min
No Credit
Free
Lung Cancer Considered in Greek: Part II
Podcast | Greek | 2024 | 60 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Lung Cancer Considered in Greek: Part II
Podcast | Greek | 2024 | 60 Min
No Credit
Free
Clinical Discussion in the Management of Early-Stage NSCLC
Podcast | English | 2024 | 54 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
Clinical Discussion in the Management of Early-Stage NSCLC
Podcast | English | 2024 | 54 Min
No Credit
Free
The Management Of CNS Metastases In Driver-Negative NSCLC
Podcast | English | 2024 | 47 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Management Of CNS Metastases In Driver-Negative NSCLC
Podcast | English | 2024 | 47 Min
No Credit
Free
LCC In Romanian
Podcast | Romanian | 2024 | 35 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
LCC In Romanian
Podcast | Romanian | 2024 | 35 Min
No Credit
Free
The Importance of Waiting for Biomarker Results in NSCLC
Podcast | English | 2024 | 50 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Importance of Waiting for Biomarker Results in NSCLC
Podcast | English | 2024 | 50 Min
No Credit
Free
LCC in Italian: First Line Treatment Options for EGFR Mutant NSCLC
Podcast | Italian | 2024 | 47 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
LCC in Italian: First Line Treatment Options for EGFR Mutant NSCLC
Podcast | Italian | 2024 | 47 Min
No Credit
Free
FDA Approval: Tarlatamab
Podcast | English | 2024 | 31 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
FDA Approval: Tarlatamab
Podcast | English | 2024 | 31 Min
No Credit
Free
ASCO 2024 Highlights Part 2
Podcast | English | 2024 | 49 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
ASCO 2024 Highlights Part 2
Podcast | English | 2024 | 49 Min
No Credit
Free
2024 ASCO Highlights Webinar
Webinar | English | 2024 | 60 Min
1 ACCME
1 Certificate of Attendance
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
2024 ASCO Highlights Webinar
Webinar | English | 2024 | 60 Min
Multiple Credits
Free
ASCO 2024 Highlights Part 1 - Plenary
Podcast | English | 2024 | 48 Min
No Credit
Free
Learning Activity Title
Learning Activity Title
Learning Activity Title
ASCO 2024 Highlights Part 1 - Plenary
Podcast | English | 2024 | 48 Min
No Credit
Free
Course
1
to
20
of
287
×
Please select your language
1
English